Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/30/2007 First Published: 4/23/2004


1.		Phase II Study of Fludeoxyglucose F18 Positron Emission Tomography for Pre- and Post-treatment Assessment in Patients With Locally Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Diagnostic, Treatment				Active				18 and over				NCI				ACRIN-6668 RTOG-0235, NCT00083083

Last Modified: 8/23/2008 First Published: 11/14/2007


2.		Phase II Study of the Effect of Zoledronic Acid on Standardized Uptake Value By Positron Emission Tomography in Patients With Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic				Active				18 and over				NCI				WSU-2006-136 2006-136, NCT00559897

Last Modified: 4/10/2008 First Published: 7/6/2007


3.		Phase II Study of Radiofrequency Ablation and External-Beam Radiation Therapy in Patients With Medically Inoperable Stage IA or Select Stage IB Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic, Treatment				Active				18 and over				NCI				CCCWFU-62306 CCCWFU-IRB00001334, CCCWFU # 62306, NCT00499447


4.		Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Diagnostic				Active				18 and over				NCI, Other				UMCC 2006.040 NCT00603057

Last Modified: 12/13/2008 First Published: 8/11/2008


5.		Phase I Study of Optical Coherence Tomography of the Airway of Patients Undergoing Pneumonectomy or Lobectomy for Malignant or Benign Lung Processes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Diagnostic				Active				Not specified				NCI				CASE-1508 CASE1508, CASE-1508-CC483, NCT00733252

Last Modified: 11/3/2008 First Published: 2/21/2007


6.		Prospective Study of Epigenetic Alterations in Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Mediastinal or Chest Wall Neoplasms, or Pulmonary Metastases from Cancers of Non-Thoracic Origin

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Diagnostic, Tissue collection/Repository				Active				Any age				NCI				NCI-06-C-0014 NCI-P6650, NCT00447447

Last Modified: 11/5/2008 First Published: 1/5/2007


7.		Study of Fludeoxyglucose F 18 Positron Emission Tomography/CT Scanning in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				18 and over				NCI				ACRIN-6678 NCT00424138

First Published: 8/8/2008


8.		Pilot Study of Radioguided Detection of Lymph Node Metastasis Using Fludeoxyglucose F 18 in Patients With Resectable Stage I-II Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				18 and over				NCI				RPCI-I-97306 I 97306, NCT00732563

Select All on One Page